COMMUNIQUÉS West-GlobeNewswire

Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
01/10/2019
Data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow Could Lead to Improvement in the Clinical Management of Gynecological Cancers SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR [...]
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
01/10/2019
Biopharma star brings extensive translational research experience as company advances its clinical indications OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug [...]
PDMR Dealing/Issue of Equity
01/10/2019
Cambridge, UK and Indianapolis, US – 1 October 2019: Acacia Pharma Group plc (the "Company), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and [...]
CRISPR Therapeutics to Present at Upcoming Investor Conferences
01/10/2019
ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting
01/10/2019
Oral presentation to highlight Phase 1 data on safety, tolerability and target engagement of losmapimod in treatment of FSHD Company also announces updated preclinical data on FTX-6058 for potential treatment of sickle [...]
Microbix Presenting at StableView TECH19 Conference
01/10/2019
Meetings with Growth-Oriented Investors, October 3, 2019 MISSISSAUGA, Ontario, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix ® ), an innovator of clinical diagnostic materials and [...]
Constellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors
01/10/2019
CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Amicus Therapeutics to Present at Upcoming Medical and Investor Conferences in October 2019
01/10/2019
CRANBURY, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at the following medical and investor conferences in October. Upcoming Medical Conferences: An [...]
Scilex Announces New Medicaid Agreements with CA & FL
01/10/2019
PALO ALTO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Scilex Holding Company (Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), is excited to announce that its subsidiary, Scilex [...]
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
01/10/2019
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity. Amsterdam, The Netherlands – 1st October 2019 Esperite N.V. (the Group) confirmed on 22nd February 2019 the intentions [...]
TLC Announces Initiation of Phase III Pivotal Clinical Trial of TLC599 for the Treatment of Osteoarthritis Knee Pain
01/10/2019
- Phase II results showed statistically significant pain relief through 24 weeks - Phase III to evaluate efficacy of single and repeated doses up to 52 weeks SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 01, 2019 [...]
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
01/10/2019
- Oerth Bio to utilize Arvinas’ PROTAC® technology to develop innovative new agricultural products to improve crop yields - John Dombrosky Announced as CEO of Oerth Bio - Transaction had been formally closed on July 15 [...]
Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon
01/10/2019
October 1, 2019 Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device [...]
Integrated Cannabis’ Ganja Gold takes Delivery of Fully Automated Proprietary Pre-Roll Manufacturing Machine
01/10/2019
VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), a multi-state brand operator in California and [...]
iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest
01/10/2019
Company to exhibit ProFound AI for 2D and 3D Mammography in Europe NASHUA, N.H. and BUDAPEST, Hungary, Oct. 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]
Eurobio Scientific joins the Enternext PEA PME 150 index
01/10/2019
Eurobio Scientific joins the Enternext PEA PME 150 index Paris, October 1st 2019 – 8:00 am Eurobio Scientific ( FR0013240934, ALERS), the leading French group in the field of in vitro medical diagnostics and life [...]
Eurobio Scientific entre dans l’indice Enternext PEA PME 150
01/10/2019
Eurobio Scientific entre dans l’indice Enternext PEA PME 150 Paris, le 1 er octobre 2019 – 8h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de [...]
Innate Pharma presents early clinical data on IPH5401 and monalizumab at the ESMO 2019 congress
01/10/2019
IPH5401 dose-escalation study in combination with durvalumab in advanced solid tumors, STELLAR-001, shows manageable safety profile Initiation of two expansion cohorts in non-small cell lung cancer (NSCLC) with [...]
INNATE PHARMA PRÉSENTE DES RESULTATS CLINIQUES PRELIMINAIRES SUR IPH5401 ET MONALIZUMAB AU CONGRÈS DE L’ESMO 2019
01/10/2019
Profil de sécurité gérable de la combinaison d’IPH5401 avec durvalumab dans l’étude en escalade de dose STELLAR-001 dans des tumeurs solides avancées Deux extensions de cohorte ont démarré : dans le cancer du poumon non [...]

Pages